Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta
- PMID: 8126064
- DOI: 10.1002/jcp.1041580303
Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta
Abstract
The role of receptor-bound urokinase-type plasminogen activator (uPA) in cellular activation of latent transforming growth factor-beta (LTGF-beta) was investigated in a model system of mouse LB6 cells transfected with either a human uPA receptor cDNA (LhuPAR+), a human prouPA cDNA (LhuPA), or a control neomycin-resistance cDNA (Lneo). When LhuPAR+ cells were co-cultured with LhuPA cells, the plasmin-dependent fibrinolytic activity generated was more than that observed in either homotypic cultures with fivefold greater number of LhuPA cells or co-cultures containing LhuPA and Lneo cells instead of the LhuPAR+ cells. The preferential activation of TGF-beta by co-cultures with the greatest plasmin-generation potential, LhuPAR+ and LhuPA cells, was confirmed by three independent bioassays. In the first assay, a 48% decrease in PA activity, a measure of active TGF-beta production, was observed with BAE cells treated with conditioned medium (CM) from co-cultures of LhuPA and LhuPAR+ cells. Inclusion of neutralizing antibodies to TGF-beta abrogated the inhibitory effect of CM on PA activity demonstrating that the inhibitory molecule was TGF-beta. Addition of the amino terminal fragment of uPA (ATF) or omission of plasminogen from co-cultures blocked both the fibrinolytic activity and the generation of TGF-beta activity in the CM. In the second assay, CM from co-cultures of LhuPA and LhuPAR+ cells inhibited the migration of BAE cells in a wound assay. Controls with anti-TGF-beta IgG indicated that the inhibition was due to TGF-beta. In the third assay, proliferation of mink lung epithelial cells was inhibited by CM generated by co-cultures of LhuPA and LhuPAR+ cells as compared to CM from the same cells cultured in the absence of plasminogen or to CM from a co-culture of LhuPA with LhuPAR- cells. Excess mannose-6-phosphate (M6P) blocked the generation of TGF-beta as assayed by both the BAE migration and PA assays, presumably because it interfered with cell-surface localization of LTGF-beta. Additionally, small numbers of LhuPA and LhuPAR+ cells co-cultured with BAE cells inhibited the BAE cell PA activity via the paracrine action of TGF-beta. These results support the conclusion that plasmin-dependent activation LTGF-beta by LB6 cells is promoted by the surface localization of uPA by its receptor.
Similar articles
-
THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.J Cell Physiol. 1995 Aug;164(2):334-43. doi: 10.1002/jcp.1041640214. J Cell Physiol. 1995. PMID: 7622580
-
Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.J Cell Physiol. 1993 Dec;157(3):528-34. doi: 10.1002/jcp.1041570312. J Cell Physiol. 1993. PMID: 8253864
-
Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.Exp Cell Res. 1999 Aug 25;251(1):111-20. doi: 10.1006/excr.1999.4561. Exp Cell Res. 1999. PMID: 10438576
-
The plasminogen activator inhibitor system in bone cell function.Clin Orthop Relat Res. 1995 Apr;(313):54-63. Clin Orthop Relat Res. 1995. PMID: 7641498 Review.
-
Influence of urokinase on cell proliferation and invasion.Blood Coagul Fibrinolysis. 1990 Dec;1(6):717-20. Blood Coagul Fibrinolysis. 1990. PMID: 1966799 Review.
Cited by
-
Cyclical strain modulates metalloprotease and matrix gene expression in human tenocytes via activation of TGFβ.Biochim Biophys Acta. 2013 Dec;1833(12):2596-2607. doi: 10.1016/j.bbamcr.2013.06.019. Epub 2013 Jul 2. Biochim Biophys Acta. 2013. PMID: 23830915 Free PMC article.
-
Latency and activation in the control of TGF-beta.J Mammary Gland Biol Neoplasia. 1996 Oct;1(4):353-63. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887509 Review.
-
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.ISRN Dermatol. 2013 Jul 18;2013:597927. doi: 10.1155/2013/597927. eCollection 2013. ISRN Dermatol. 2013. PMID: 23984088 Free PMC article.
-
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.Curr Drug Targets. 2011 Nov;12(12):1782-9. doi: 10.2174/138945011797635803. Curr Drug Targets. 2011. PMID: 21707474 Free PMC article. Review.
-
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5899-904. doi: 10.1073/pnas.93.12.5899. Proc Natl Acad Sci U S A. 1996. PMID: 8650190 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous